Aldo-keto reductase family 1 member C3 — Drug Target
All drugs that target Aldo-keto reductase family 1 member C3 — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Prostaglandin Analog [EPC] · cloxazolam
Marketed (1)
- Lumigan · Prostaglandin Analog [EPC] · Cardiovascular
Lumigan works by increasing the outflow of fluid from the eye to reduce pressure.
Phase 2 pipeline (1)
- Cloxazolazepam · cloxazolam · Other
Cloxazolazepam works by inhibiting the enzyme Aldo-keto reductase family 1 member C3.